Midline Catheter Market: Growth, Trends & Forecast to 2035

Introduction

The Global Midline Catheter Market is witnessing steady growth, driven by the increasing number of hospital admissions, the rising prevalence of chronic diseases, an aging global population, and advancements in vascular access technology. Midline catheters provide an important option for patients requiring extended intravenous access for therapies such as oncology treatment, antibiotic administration, and fluid or blood product delivery. Growing emphasis on patient comfort, reduced procedural complexity, and improved healthcare delivery is further supporting market expansion.

Get Free Sample Of This Premium Report

https://www.decisionsadvisors.com/request-sample/DAR4329

Midline Catheter Market Insights

Based on Decisions Advisors' market research, the Global Midline Catheter Market was valued at approximately USD 3.15 Billion in 2024 and is projected to reach around USD 6.73 Billion by 2035.

From 2025 to 2035, the market is expected to expand at a CAGR of 7.15%. The increasing need for reliable vascular access, growing chronic disease burden, rising healthcare expenditure, and technological advancements in catheter design are among the key factors supporting market growth.

Within the Product Type segment, Single Lumen Catheters accounted for the largest market share in 2024. Their ease of use and suitability for intravenous therapy have supported their widespread adoption.

By Material, Polyurethane dominated the market in 2024. Its flexibility, strength, and resistance to kinking make it a widely used material for midline catheter applications.

Based on Application, Oncology accounted for the highest revenue share in 2024, supported by the need for reliable vascular access during chemotherapy and other cancer treatments.

Other Key Findings

• Asia-Pacific is anticipated to hold the largest share of the global midline catheter market over the forecast period, supported by rising healthcare expenditure, improving healthcare infrastructure, and increasing demand for medical services.
• North America is expected to record the fastest CAGR during the forecast period, driven by advanced healthcare systems, chronic disease prevalence, favorable reimbursement conditions, and technological innovation.
• Increasing adoption of midline catheters is being supported by the growing requirement for longer-term vascular access in hospital and home healthcare settings.
• Advances in catheter materials and designs are focused on improving patient comfort, safety, dwell time, and resistance to complications.
• The market continues to face challenges associated with catheter-related infections, complications, strict regulatory requirements, and the need for rigorous quality and safety standards.

Report Summary

The published report identifies Asia-Pacific as the anticipated largest regional market, while North America is projected to grow at the fastest CAGR during the forecast period.

Segmentation Covered

The regional analysis further covers major markets including the United States, Canada, Mexico, Germany, the UK, France, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Brazil, Argentina, UAE, Saudi Arabia, Qatar, and South Africa.

Report Coverage

The Global Midline Catheter Market report provides comprehensive coverage of:

• Revenue forecasts and market sizing
• Market segmentation analysis
• Regional and country-level analysis
• Market growth drivers
• Industry trends and opportunities
• Market restraints and challenges
• Product and material developments
• Competitive landscape
• Company strategies
• Product launches and innovations
• Partnerships, mergers, and acquisitions
• Regulatory and healthcare market developments

The report also profiles major companies and evaluates their product offerings, business strategies, geographic presence, segment positioning, and competitive capabilities.

Companies

• AngioDynamics, Inc.
• Argon Medical Devices
• BD
• Boston Scientific Corporation
• Cook
• Fresenius Kabi AG
• Haolang Technology (Foshan) Limited Co.
• Harsoria Healthcare Pvt Ltd
• Health Line Medical Products
• ICU Medical, Inc.
• Medtronic plc
• Smiths Medical
• Spectrum Vascular
• Teleflex
• VYGON
• Others

These companies are analyzed in the report based on factors including product offerings, geographic presence, business strategies, market positioning, and recent developments.

Recent Market Developments

• In September 2025, Terumo launched Japan's first indwelling needle-type midline catheter, SurFlo Midela, designed as a minimally invasive vascular access option.
• In October 2025, the FDA cleared Access Vascular's HydroMid and HydroPICC catheters with a new anti-thrombogenic indication.
• In June 2022, Teleflex launched its Arrow Pressure Injectable Midline Catheter across Europe, the Middle East, and Africa, designed to support pressure injections and improve line identification.

Want detailed insights, forecasts, and competitive analysis?

Check out the full Global Midline Catheter Market report:

https://www.decisionsadvisors.com/reports/midline-catheter-market